Terms: = Lymphoma AND POU2AF1, OBF1, 5450, ENSG00000110777, BOB1, OCAB, Q16633, OBF-1 AND Treatment
16 results:
1. Transcriptional Coactivator bob1 (obf1, OCA-B) Modulates the Specificity of DNA Recognition by the POU-Domain Factors OCT1 and OCT2 in a Monomeric Configuration.
Nazarov IB; Zilov DS; Gordeev MN; Potapenko EV; Yeremenko N; Tomilin AN
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254723
[TBL] [Abstract] [Full Text] [Related]
2. Losing CD45 and various B-cell markers in a case of MYC-driven pediatric high-grade B-cell lymphoma, not otherwise specified that transformed from Burkitt's lymphoma during rituximab-containing treatments: a case report.
Xue X; Fu L; Qiu T; Cao Z; Wang X; Rao W; Luo Y; He L; Feng X
Virchows Arch; 2023 Jul; 483(1):111-116. PubMed ID: 36383247
[TBL] [Abstract] [Full Text] [Related]
3. [ALK-positive large B-cell lymphoma with EBV infection or cyclin D1 expression: a clinicopathological analysis of 3 cases].
Wu WN; Xiang CX; Ma DS; Liu GZ; Liu H
Zhonghua Bing Li Xue Za Zhi; 2022 Jun; 51(6):506-511. PubMed ID: 35673721
[No Abstract] [Full Text] [Related]
4. Lymphocyte-depleted classic Hodgkin lymphoma with primary extranodal disease: Two cases that highlight the combination of immunodeficiency and immune escape in the pathogenesis.
Tsuyuki Y; Kohno K; Inagaki Y; Sakai Y; Kosugi H; Takahashi E; Suzuki Y; Shimada S; Kato S; Takahara T; Satou A; Shimoyama Y; Nakamura S; Asano N; Sakakibara A
J Clin Exp Hematop; 2021; 61(3):173-179. PubMed ID: 34511545
[TBL] [Abstract] [Full Text] [Related]
5. Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK + LBCL): a systematic review of clinicopathological features and management.
Castillo JJ; Beltran BE; Malpica L; Marques-Piubelli ML; Miranda RN
Leuk Lymphoma; 2021 Dec; 62(12):2845-2853. PubMed ID: 34151703
[TBL] [Abstract] [Full Text] [Related]
6. Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature.
Nagaharu K; Masuya M; Kageyama Y; Yamaguchi T; Ito R; Kawakami K; Ito M; Katayama N
J Med Case Rep; 2018 May; 12(1):151. PubMed ID: 29843820
[TBL] [Abstract] [Full Text] [Related]
7. Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014.
Mokdad AH; Dwyer-Lindgren L; Fitzmaurice C; Stubbs RW; Bertozzi-Villa A; Morozoff C; Charara R; Allen C; Naghavi M; Murray CJ
JAMA; 2017 Jan; 317(4):388-406. PubMed ID: 28118455
[TBL] [Abstract] [Full Text] [Related]
8. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.
Krysiak K; Gomez F; White BS; Matlock M; Miller CA; Trani L; Fronick CC; Fulton RS; Kreisel F; Cashen AF; Carson KR; Berrien-Elliott MM; Bartlett NL; Griffith M; Griffith OL; Fehniger TA
Blood; 2017 Jan; 129(4):473-483. PubMed ID: 28064239
[TBL] [Abstract] [Full Text] [Related]
9. TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor bob1.
Jahn L; Hombrink P; Hagedoorn RS; Kester MG; van der Steen DM; Rodriguez T; Pentcheva-Hoang T; de Ru AH; Schoonakker MP; Meeuwsen MH; Griffioen M; van Veelen PA; Falkenburg JH; Heemskerk MH
Blood; 2017 Mar; 129(10):1284-1295. PubMed ID: 28053195
[TBL] [Abstract] [Full Text] [Related]
10. Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma.
Park HY; Lee SB; Yoo HY; Kim SJ; Kim WS; Kim JI; Ko YH
Oncotarget; 2016 Dec; 7(52):86433-86445. PubMed ID: 27835906
[TBL] [Abstract] [Full Text] [Related]
11. Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis.
Wang T; Xu B; Fan R; Liu Z; Gong D
J Clin Lipidol; 2016; 10(3):646-9. PubMed ID: 27206953
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathologic characteristics of HIV/AIDS-related plasmablastic lymphoma.
Wang D; Zheng Y; Zeng D; Yang Y; Zhang X; Feng Y; Lu H
Int J STD AIDS; 2017 Mar; 28(4):380-388. PubMed ID: 27164966
[TBL] [Abstract] [Full Text] [Related]
13. Very late relapse of PTLD 10 yr after allogeneic HSCT and nine yr after stopping immunosuppressive therapy.
Helgestad J; Rosthøj S; Pedersen MH; Johansen P; Iyer V; Østergaard E; Heilmann C
Pediatr Transplant; 2014 Feb; 18(1):E35-9. PubMed ID: 24168387
[TBL] [Abstract] [Full Text] [Related]
14. B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology.
Carbone A; Gloghini A; Aiello A; Testi A; Cabras A
Hum Pathol; 2010 May; 41(5):621-31. PubMed ID: 20398809
[TBL] [Abstract] [Full Text] [Related]
15. Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma.
Ushmorov A; Leithäuser F; Sakk O; Weinhaüsel A; Popov SW; Möller P; Wirth T
Blood; 2006 Mar; 107(6):2493-500. PubMed ID: 16304050
[TBL] [Abstract] [Full Text] [Related]
16. Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression.
Ushmorov A; Ritz O; Hummel M; Leithäuser F; Möller P; Stein H; Wirth T
Blood; 2004 Nov; 104(10):3326-34. PubMed ID: 15284123
[TBL] [Abstract] [Full Text] [Related]
